Human tumor assay coverage
This article was originally published in The Gray Sheet
Executive Summary
Laboratory and Diagnostic Services Panel of MCAC convenes Nov. 15 from 8 a.m. to 4 p.m. and Nov. 16 from 8 a.m. to 12 noon in Baltimore to discuss human tumor assays, such as Oncotech's extreme drug resistance test, which previously has been the subject of an admininstrative law judge appeal (1"The Gray Sheet" July 26, p. 12)